MPs hit out at NHS reforms
January 18, 2011GP consortia, Health Select Committee, NHS, NHS reforms, PCTs
MPs have come out against the NHS White Paper, saying it has caused wide spread uncertainty at a time when …
European Commission launches new generic deal review
January 18, 2011Sales and Marketing European Commission, anti-trust investigation, competition, generics
The European Commission has asked a number of firms to submit copies of their patent settlements in 2010 to see …
GSK takes £2.2bn hit from Avandia claims
January 18, 2011Sales and Marketing Avandia, GSK, GlaxoSmithKline, rosiglitazone
GlaxoSmithKline’s Avandia woes are continuing, with the company admitting it expects to take a mammoth legal charge over the troubled …
Merck Serono and Domain to co-develop Parkinson’s drugs
January 18, 2011Research and Development Domain Therapeutics, Merck KGaA, Merck Serono, PAM, Parkinson's disease, Parkinson’s disease, Positive Allosteric Modulator, mGluR4, metabotropic glutamate receptor 4
Merck Serono is to work with French biotech company Domain Therapeutics to develop a new treatment for Parkinson’s disease and …
Merck suffers late-stage blow to vorapaxar
January 18, 2011Research and Development ACS, Merck & Co, acute coronary syndrome, anticoagulant, heart attack, peripheral arterial disease, stroke, vorapaxar
An increased risk of bleeding caused by pipeline drug vorapaxar has dealt Merck a major blow.The Data and Safety Monitoring …
BMS and Sanofi recall 64 million Avalide tablets
January 18, 2011Manufacturing and Production Avalide, Avapro, Bristol-Myers Squibb, GMP, Good Manufacturing Practice, Sanofi-Aventis, hypertension, irbesartan
Bristol-Myers Squibb and Sanofi-Aventis have started another massive recall of their antihypertensive product Avalide because a manufacturing defect could affect …
Merck taps Parexel to help it meet biosimilar ambitions
January 18, 2011Research and Development Merck & Co, Parexel, biosimilars
Merck & Co has enlisted the aid of contract research organisation Parexel to help it develop biosimilar versions of some …
Top doctors believe PCTs should stay
January 17, 2011BMA, NHS, NHS reforms, PCTs, Royal College of GP
Leading GPs have criticised the government’s wide-ranging NHS reforms, saying minor structural changes are all the health service needs. A …
FDA issues Multaq liver warning
January 17, 2011Sales and Marketing FDA, Multaq, atrial fibrilation, dronedarone
US regulators have warned doctors and patients about the risk of severe liver injury associated with Sanofi-Aventis’ atrial fibrillation (AF) …
Digital Pharma: Sanofi launches diabetes blog
January 17, 2011Medical Communications, Sales and Marketing Digital Pharma blog, Sanofi-Aventis, blog, diabetes
Sanofi-Aventis has ramped up its social media efforts with the launch of a blog about diabetes for US consumers. The …
Shire says new plant will add to Replagal, Vpriv capacity
January 17, 2011Manufacturing and Production Cerezyme, Replagal, Shire, Vpriv
UK drugmaker Shire has completed construction of a new manufacturing facility for its orphan disease drugs Replagal and Vpriv, and …
Roche finance chief steps down
January 17, 2011Sales and Marketing Alan Hippe, Erich Hunziker, Roche, appointment, sales and marketing
Roche’s chief financial officer Erich Hunziker is to retire at the end of March after ten years with the company. …
Diabetes drugs show promise in Alzheimer’s
January 17, 2011Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide
Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …
Digital Pharma: NHS thrombosis e-learning
January 14, 2011Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism
The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …
Gates Foundation funds TB drug discovery
January 14, 2011Research and Development Bill and Melinda Gates Foundation, IDRI, Infectious Disease Research Institute, Lilly TB Drug Discovery Initiative, TB, lilly, tuberculosis
Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …
GSK moves Crohn’s disease drug into phase III
January 14, 2011Research and Development ChemoCentryx, Crohn’s disease, GSK’786, GlaxoSmithKline, Traficet-EN
GlaxoSmithKline and its partner ChemoCentryx have started late-stage trials of GSK’786 for Crohn’s disease. The initial study is a randomised, …
Publicis acquires French comms agency
January 14, 2011Medical Communications Digital District, François Sarkozy, Healthcare Consulting, In-Sync, Publicis Healthcare Consulting, Resolute Communications, Yannick Sabatin, publicis
Paris-based communications giant Publicis Groupe has bought a health comms agency set up by the brother of French president Nicolas …
Anti-cancer stem cell drug starts clinical trials
January 14, 2011Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers
OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …
Red Health boosts account team
January 14, 2011Medical Communications Jo Tubbs, Nicole Tripney, appointment, medical communications, red consultancy, red health
The Red Consultancy has started the year with two new hires for its specialist health team, Red Health. Account director …
End of the line for GSK’s resveratrol
January 14, 2011Research and Development GSK, GlaxoSmithKline, SRT2104, SRT2379, SRT501, Sirtris, multiple myeloma, resveratrol
GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
